title: Infliximab-associated lymphoproliferative disorders.
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Hoshida
authors.forename: Shigeo
authors.initials: S
authors.lastname: Yamamoto
authors.forename: Naoki
authors.initials: N
authors.lastname: Wada
authors.forename: Jing-Xian
authors.initials: JX
authors.lastname: Xu
authors.forename: Toru
authors.initials: T
authors.lastname: Sasaki
authors.forename: Katsuyuki
authors.initials: K
authors.lastname: Aozasa
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D006801:Humans; D000069285:Infliximab; D008232:Lymphoproliferative Disorders / Q000139:chemically induced*; D008875:Middle Aged; D012307:Risk Factors
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab